These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14703896)

  • 21. [Values of serum copper and serum free copper in the diagnosis and monitoring of Wilson's disease and its carriers].
    Zhou XX; Li XH; Huang HW; Liu B; Zhu RL; Liang YY; Zhu JZ; Liang XL
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2757-60. PubMed ID: 22322054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is low serum tocopherol in Wilson's disease a significant symptom?
    Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB
    J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
    Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
    Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
    Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of treatment of Wilson's disease--own observations.
    Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
    Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc].
    Dastych M
    Vnitr Lek; 1999 Apr; 45(4):217-9. PubMed ID: 11045182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current principles of Wilson's disease--diagnosis and treatment].
    Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
    Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
    Brewer GJ; Dick RD; Grover DK; LeClaire V; Tseng M; Wicha M; Pienta K; Redman BG; Jahan T; Sondak VK; Strawderman M; LeCarpentier G; Merajver SD
    Clin Cancer Res; 2000 Jan; 6(1):1-10. PubMed ID: 10656425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
    Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
    J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
    Hayashi H; Ueno T; Yano M; Okada T; Mabuchi H
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1627-8. PubMed ID: 16174091
    [No Abstract]   [Full Text] [Related]  

  • 35. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up.
    Larnaout A; Ammar N; Mourad Z; Naji S; Hentati F
    Neuropediatrics; 2008 Jun; 39(3):176-8. PubMed ID: 18991198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
    Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical experience of Chinese patients with Wilson's disease.
    Pan JJ; Chu CJ; Chang FY; Lee SD
    Hepatogastroenterology; 2005; 52(61):166-9. PubMed ID: 15783020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M; Percl M; Jadresin O; Kolacek S
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
    Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
    Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
    Lech T; Sadlik JK
    Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.